Hemosiderosis Workup

  • Author: Galia D Napchan, MD; Chief Editor: Michael R Bye, MD   more...
 
Updated: Apr 16, 2012
 

Laboratory Studies

The following studies are indicated in pulmonary hemosiderosis (PH)

  • CBC count
    • Microcytic and hypochromic anemia are present.
    • Eosinophilia has been present in approximately one eighth of reported cases. Most of these cases are associated with Heiner syndrome.
  • Stool guaiac test results - Frequently positive
  • Analysis of gastric lavages - Positive for iron-laden macrophages
  • Immunoglobulin E level - High levels possible in Heiner syndrome
  • Serologic analysis
    • Titers of serum precipitins to casein and lactalbumin are elevated in Heiner syndrome.
    • Circulating anti-GBM antibodies are present in patients with Goodpasture syndrome.
    • Antineutrophil cytoplasmic antibodies (C-ANCA) are present in patients with Wegener granulomatosis.
    • Antinuclear antibodies and anti-DNA antibodies are positive in systemic lupus erythematosus (SLE).
    • Serologic markers for celiac disease include gliadin antibodies and reticulin antibodies. If findings are positive, then consider performing a jejunal biopsy.
  • Sputum analysis
    • Perform stain, culture, and sensitivity for bacteria, fungi, and mycobacteria.
    • Cytology may reveal hemosiderin-laden macrophages, which suggests bleeding during the preceding months and ongoing bleeding for more than 3-4 days.
  • Urinalysis - Hematuria and/or proteinuria in pulmonary hemosiderosis secondary to immune-mediated glomerulonephritis, Goodpasture syndrome, and SLE
  • Prothrombin time/activated partial thromboplastin time - Used to rule out bleeding disorders
  • von Willebrand factor antigen and Ristocetin cofactor levels - May be obtained to assess for von Willebrand disease
  • IgA antiendomysial antibody level - Facilitates the diagnosis of celiac disease (However, histologic examination of a duodenal biopsy sample remains the criterion standard.)
Next

Imaging Studies

  • Chest radiography
    • The most common finding is patchy alveolar infiltrates that are often perihilar or basilar and are usually bilateral. Infiltrates may be migratory.
    • Interstitial changes are found in long-standing pulmonary hemosiderosis.
    • Occasionally, chest radiograph findings may be normal.
    • Hilar lymph nodes may be enlarged, especially in the acute stage.
    • Resolution, often with a persistent reticular pattern, occurs in less than 2 weeks.
  • CT scanning
    • May show areas of increased pulmonary density due to intra-alveolar hemorrhage and/or hemosiderin-laden macrophages, even when the chest radiograph findings appear normal
    • Useful in distinguishing superimposed infections from fresh hemorrhages
    • Helpful if focal pulmonary causes, endobronchial lesions, or vascular malformations are suspected
    • Useful in demonstrating the exact localization of lesions for open lung biopsy
  • Nuclear scanning
    • The lungs of healthy patients do not take up RBCs labeled with chromium isotope (51 Cr) or technetium Tc 99 (99 Tc) pertechnetate.
    • Scans with abnormal pulmonary uptake 12-24 hours after the injection have been observed in patients with pulmonary hemorrhage.
  • Ventilation/perfusion scanning - Important if pulmonary embolism is suspected
Previous
Next

Other Tests

  • After an episode of acute hemorrhage, pulmonary function testing (PFT) demonstrates decreased compliance, airflow obstruction, and an increase in the diffusing capacity for carbon monoxide (due to increased hemoglobin uptake of carbon monoxide by sequestrated RBCs in the lungs).
  • In long-standing pulmonary hemosiderosis, PFT results demonstrate a restrictive pattern.
Previous
Next

Procedures

  • Flexible bronchoscopy
    • Performed to assess the anatomy of the airways for pulmonary malformations, endobronchial lesions, retained foreign body, and airway compression
    • Used to perform bronchoalveolar lavage (BAL)
  • Bronchoalveolar lavage
    • Hemosiderin-laden macrophages: Hemosiderin-laden macrophages are diagnostic for PH. They are usually cleared from the alveoli and airways within a few months of the bleeding. The microphages are observed 2-3 days after acute bleeding.
    • Malignant cells in cases of neoplasms (extremely uncommon in pediatric patients)
    • Positive stains and cultures for bacteria, fungi, and mycobacteria in cases of infection
  • Open lung biopsy
Previous
Next

Histologic Findings

  • Findings in the lung vary with the stage of the disease.
  • In the early stages, interstitial and intra-alveolar hemorrhages predominate, with collections of both free hemosiderin and hemosiderin-laden macrophages found in the alveolar spaces and in the interstitium.
  • As the disease progresses, interstitial fibrosis develops.
  • Immunofluorescence and electron microscopy of the lung and kidney tissue may differentiate idiopathic pulmonary hemosiderosis (IPH) from Goodpasture syndrome and immune complex–mediated diseases.
Previous
 
 
Contributor Information and Disclosures
Author

Galia D Napchan, MD  Pediatric Pulmonologist, Joe DiMaggio Children's Hospital

Galia D Napchan, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Coauthor(s)

Isaac Talmaciu, MD  Clinical Assistant Professor, Department of Pediatrics, Florida Atlantic University School of Medicine

Isaac Talmaciu, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Specialty Editor Board

Thomas Scanlin, MD  Chief, Division of Pulmonary Medicine and Cystic Fibrosis Center, Department of Pediatrics, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School

Thomas Scanlin, MD is a member of the following medical societies: American Association for the Advancement of Science, American Society for Biochemistry and Molecular Biology, American Thoracic Society, Society for Pediatric Research, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Charles Callahan, DO  Professor, Deputy Chief of Clinical Services, Walter Reed Army Medical Center

Charles Callahan, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, American College of Osteopathic Pediatricians, American Thoracic Society, Association of Military Surgeons of the US, and Christian Medical & Dental Society

Disclosure: Nothing to disclose.

Mary E Cataletto, MD  Director of Children's Sleep Services, Winthrop Sleep Disorders Center; Professor of Clinical Pediatrics, State University of New York at Stony Brook

Mary E Cataletto, MD is a member of the following medical societies: American Academy of Pediatrics and American College of Chest Physicians

Disclosure: Shering Plough Pharmaceuticals Honoraria Consulting

Chief Editor

Michael R Bye, MD  Professor of Clinical Pediatrics, Division of Pulmonary Medicine, Columbia University College of Physicians and Surgeons; Attending Physician, Pediatric Pulmonary Medicine, Morgan Stanley Children's Hospital of New York Presbyterian, Columbia University Medical Center

Michael R Bye, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Chest Physicians, and American Thoracic Society

Disclosure: Nothing to disclose.

References
  1. Gordon IO, Cipriani N, Arif Q, Mackinnon AC, Husain AN. Update in nonneoplastic lung diseases. Arch Pathol Lab Med. Jul 2009;133(7):1096-105. [Medline].

  2. Sethi GR, Singhal KK, Puri AS, Mantan M. Benefit of gluten-free diet in idiopathic pulmonary hemosiderosis in association with celiac disease. Pediatr Pulmonol. Oct 21 2010;[Medline].

  3. Kahraman H, Köksal N, Ozkan F. Eight Years Follow-up of a Case with Idiopathic Pulmonary Hemosiderosis After Corticosteroid Therapy. N Am J Med Sci. Jan 2012;4(1):49-51. [Medline]. [Full Text].

  4. Bhatia S, Tullu MS, Vaideeswar P, Lahiri KR. Idiopathic pulmonary hemosiderosis: alveoli are an answer to anemia. J Postgrad Med. Jan-Mar 2011;57(1):57-60. [Medline].

  5. [Guideline] American College of Allergy, Asthma, & Immunology. Food allergy: a practice parameter. Ann Allergy Asthma Immunol. Mar 2006;96(3 Suppl 2):S1-68. [Medline]. [Full Text].

  6. Akyar S, Ozbek SS. Computed tomography findings in idiopathic pulmonary hemosiderosis. Respiration. 1993;60(1):63-4. [Medline].

  7. CDC. Investigation of acute idiopathic pulmonary hemorrhage among infants - Massachusetts, December 2002-June 2003. MMWR Morb Mortal Wkly Rep. Sep 10 2004;53(35):817-20. [Medline].

  8. Dearborn DG. Pulmonary hemorrhage in infants and children. Curr Opin Pediatr. Jun 1997;9(3):219-24. [Medline].

  9. Hoca, Nevin Taci. Dayioglu, Didem. Ogretensoy, Mihriban. Pulmonary hemosiderosis in association with celia disease. Lung. Sep-Oct 2006;184(5):297-300. [Medline].

  10. Ioachimescu OC, Sieber S, Kotch A. Idiopathic pulmonary haemosiderosis revisited. Eur Respir J. Jul 2004;24(1):162-70. [Medline].

  11. Katz SM, Foster E, Miller AS, Krevolin L, Schwartz AB. Goodpasture's syndrome mimicking idiopathic pulmonary hemosiderosis. Ann Clin Lab Sci. Jul-Aug 1989;19(4):280-6. [Medline].

  12. Kayser K, Plodziszewska M, Waitr E, et al. Diffuse pulmonary hemosiderosis after exposure to pesticides. A case report. Respiration. 1998;65(3):214-8. [Medline].

  13. Kiper N, Gocmen A, Ozcelik U, et al. Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): prolonged survival with low-dose corticosteroid therapy. Pediatr Pulmonol. Mar 1999;27(3):180-4. [Medline].

  14. Le Clainche L, Le Bourgeois M, Fauroux B, et al. Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine (Baltimore). Sep 2000;79(5):318-26. [Medline].

  15. Malhotra P, Aggarwal R, Aggarwal AN, et al. Coeliac disease as a cause of unusually severe anaemia in a young man with idiopathic pulmonary haemosiderosis. Respir Med. Apr 2005;99(4):451-3. [Medline].

  16. McCoy KS. Hemosiderosis. In: Taussig LM, Landau LI, eds. Pediatric Respiratory Medicine. St. Louis, Mo: Mosby; 1999:835-40.

  17. Milman N, Pedersen FM. Idiopathic pulmonary haemosiderosis. Epidemiology, pathogenic aspects and diagnosis. Respir Med. Jul 1998;92(7):902-7. [Medline].

  18. Pinto LA, Oliveira A, Collaziol S, et al. Postinfectious bronchiolitis obliterans accompanied by pulmonary hemosiderosis in childhood. J Bras Pneumol. Nov-Dec 2006;32(6):587-91. [Medline].

  19. Rossi GA, Balzano E, Battistini E, et al. Long-term prednisone and azathioprine treatment of a patient with idiopathic pulmonary hemosiderosis. Pediatr Pulmonol. Jul 1992;13(3):176-80. [Medline].

  20. Saeed MM, Woo MS, MacLaughlin EF, et al. Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest. Sep 1999;116(3):721-5. [Medline]. [Full Text].

  21. Sun LC, Tseng YR, Huang SC, et al. Extracorporeal membrane oxygenation to rescue profound pulmonary hemorrhage due to idiopathic pulmonary hemosiderosis in a child. Pediatr Pulmonol. Sep 2006;41(9):900-3. [Medline].

  22. Torres MJ, Giron MD, Corzo JL, et al. Release of inflammatory mediators after cow's milk intake in a newborn with idiopathic pulmonary hemosiderosis. J Allergy Clin Immunol. Dec 1996;98(6 Pt 1):1120-3. [Medline].

  23. Zaki M, al Saleh Q, al Mutari G. Effectiveness of chloroquine therapy in idiopathic pulmonary hemosiderosis. Pediatr Pulmonol. Aug 1995;20(2):125-6. [Medline].

Previous
Next
 
Image of a kidney viewed under a microscope. The brown areas contain hemosiderin.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.